Cytosorbents Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cytosorbents Corporation (Nasdaq: CTSO) on April 12, 2021. The report details the approval of annual compensation packages for executive officers by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation adjustments for Fiscal Year 2021.
Material Changes
The primary material change reported is the adjustment of executive compensation effective January 1, 2021, and April 12, 2021:
- Base Salary: All four executive officers received an approximate 6.0% increase in annual base salary.
- Cash Bonuses: 2020 performance-based cash bonuses were paid in 2021.
- Equity Awards: New stock options and restricted stock units (RSUs) were granted on April 12, 2021.
| Executive Officer | Position | 2021 Base Salary | Cash Bonus | Stock Options | RSUs |
|---|---|---|---|---|---|
| Phillip P. Chan, MD, PhD | CEO | $482,851 | $260,557 | 96,000 | 72,000 |
| Vincent J. Capponi | President & COO | $424,000 | $197,208 | 78,200 | 62,215 |
| Kathleen P. Bloch | CFO | $370,428 | $138,386 | 69,000 | 49,450 |
| Efthymios N. Deliargyris, MD | CMO | $408,100 | $101,640 | 63,250 | 40,000 |
Equity Terms: Stock options have a strike price of $8.99 (closing price on grant date) and a 10-year term. Options vest quarterly over three years; RSUs vest annually over two years.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, outlook, or discussion of risks and contingencies. The compensation adjustments were made based on annual performance reviews and the Company's 2020 performance.
Investor Verification Checklist
- Verify the impact of the 6.0% salary increase on the company's operating expenses for Fiscal Year 2021.
- Review the vesting schedules to understand future dilution from the 306,450 stock options and 223,665 RSUs granted.
- Confirm the strike price of $8.99 relative to the current market price of CTSO stock.
- Check subsequent filings for actual cash burn rates, as this 8-K does not disclose liquidity status.